Long-Term Effectiveness of XEN 45 Gel-Stent in Open-Angle Glaucoma Patients

References

• Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711–1720. doi:10.1016/S0140-6736(04)16257-0
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–1279. doi:10.1001/archopht.120.10.1268
   PubMed Web of Science ®Google Scholar
• Lichter PR, Musch DC, Gillespie BW, et al.; CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943–1953. doi:10.1016/S0161-6420(01)00873-9
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316. doi:10.1016/j.ophtha.2015.03.026
   PubMed Web of Science ®Google Scholar
• Landers J, Martin K, Sarkies N, Bourne R, Watson P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012;119(4):694–702. doi:10.1016/j.ophtha.2011.09.043
   PubMed Web of Science ®Google Scholar
• Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE; Collaborative Initial Glaucoma Treatment Study Group. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol. 2005;140(1):16–22. doi:10.1016/j.ajo.2005.02.013
   PubMed Web of Science ®Google Scholar
• Bar-David L, Blumenthal EZ. Evolution of glaucoma surgery in the last 25 years. Rambam Maimonides Med J. 2018;9(3):e0024. doi:10.5041/RMMJ.10345
   PubMed Web of Science ®Google Scholar
• Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23(2):96–104. doi:10.1097/ICU.0b013e32834ff1e7
   PubMed Web of Science ®Google Scholar
• Ahmed II. MIGS and the FDA: what’s in a name? Ophthalmology. 2015;122(9):1737–1739. doi:10.1016/j.ophtha.2015.06.022
   PubMed Web of Science ®Google Scholar
• Caprioli J, Kim JH, Friedman DS, et al. Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology. 2015;122(9):1795–1801. doi:10.1016/j.ophtha.2015.02.029
   PubMed Web of Science ®Google Scholar
• Grover DS, Flynn WJ, Bashford KP, et al. Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol. 2017;183:25–36. doi:10.1016/j.ajo.2017.07.023
   PubMed Web of Science ®Google Scholar
• Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I. Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma. 2017;26(12):1130–1136. doi:10.1097/IJG.0000000000000803
   PubMed Web of Science ®Google Scholar
• Schlenker MB, Gulamhusein H, Conrad-Hengerer I, et al. Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124(11):1579–1588. doi:10.1016/j.ophtha.2017.05.004
   PubMed Web of Science ®Google Scholar
• Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I; Apex Study Group. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257(5):983–996. doi:10.1007/s00417-019-04251-z
   PubMed Web of Science ®Google Scholar
• Marcos Parra MT, Salinas López JA, López Grau NS, Ceausescu AM, Pérez JJ. XEN implant device versus trabeculectomy, either alone or in combination with phacoemulsification, in open-angle glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2019;257(8):1741–1750. doi:10.1007/s00417-019-04341-y
   PubMed Web of Science ®Google Scholar
• Karimi A, Lindfield D, Turnbull A, et al. A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery. Eye. 2019;33(3):469–477. doi:10.1038/s41433-018-0243-8
   PubMed Web of Science ®Google Scholar
• Lenzhofer M, Kersten-Gomez I, Sheybani A, et al. Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study. Clin Exp Ophthalmol. 2019;47(5):581–587. doi:10.1111/ceo.13463
   PubMed Web of Science ®Google Scholar
• Ibáñez-Muñoz A, Soto-Biforcos VS, Rodríguez-Vicente L, et al. XEN implant in primary and secondary open-angle glaucoma: A12-month retrospective study. Eur J Ophthalmol. 2020;30(5):1034–1041. doi:10.1177/1120672119845226
   PubMed Web of Science ®Google Scholar
• Fea AM, Bron AM, Economou MA, et al. European study of the efficacy of a cross-linked gel stent for the treatment of glaucoma. J Cataract Refract Surg. 2020;46(3):441–450. doi:10.1097/j.jcrs.0000000000000065
   PubMed Web of Science ®Google Scholar
• Wagner FM, Schuster AK, Emmerich J, Chronopoulos P, Hoffmann EM. Efficacy and safety of XEN®-implantation vs. trabeculectomy: data of a “real-world” setting. PLoS One. 2020;15(4):e0231614. doi:10.1371/journal.pone.0231614
   PubMed Web of Science ®Google Scholar
• Theilig T, Rehak M, Busch C, Bormann C, Schargus M, Unterlauft JD. Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study. Sci Rep. 2020;10(1):19337. doi:10.1038/s41598-020-76551-y
   PubMed Web of Science ®Google Scholar
• Panarelli JF, Yan DB, Francis B, Craven ER, Gel Stent XEN. Open conjunctiva technique: a practical approach paper. Adv Ther. 2020;37(5):2538–2549. doi:10.1007/s12325-020-01278-1
   PubMed Web of Science ®Google Scholar
• Vera V, Gagne S, Myers JS, Ahmed IIK. Surgical approaches for implanting xen gel stent without conjunctival dissection. Clin Ophthalmol. 2020;14:2361–2371. doi:10.2147/OPTH.S265695
   PubMed Web of Science ®Google Scholar
• Tan NE, Tracer N, Terraciano A, Parikh HA, Panarelli JF, Radcliffe NM. Comparison of safety and efficacy between Ab interno and Ab externo approaches to XEN gel stent placement. Clin Ophthalmol. 2021;15:299–305. doi:10.2147/OPTH.S292007
   PubMed Web of Science ®Google Scholar
• Reitsamer H, Vera V, Ruben S, et al. Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study. Acta Ophthalmol. 2022;100(1):e233–e245. doi:10.1111/aos.14886
   PubMed Web of Science ®Google Scholar
• Gillmann K, Bravetti GE, Rao HL, Mermoud A, Mansouri K. Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors. Acta Ophthalmol. 2021;99(4):e531–e539. doi:10.1111/aos.14605
   PubMed Web of Science ®Google Scholar
• Gabbay IE, Goldberg M, Allen F, et al. Efficacy and safety data for the Ab interno XEN45 gel stent implant at 3 Years: a retrospective analysis. Eur J Ophthalmol. 2021;11206721211014381. doi:10.1177/11206721211014381
   Web of Science ®Google Scholar
• Nuzzi R, Gremmo G, Toja F, Marolo P. A retrospective comparison of trabeculectomy, baerveldt glaucoma implant, and microinvasive glaucoma surgeries in a three-year follow-up. Semin Ophthalmol. 2021;36(8):839–849. doi:10.1080/08820538.2021.1931356
   PubMed Web of Science ®Google Scholar
• Cappelli F, Cutolo CA, Olivari S, et al. Trabeculectomy versus Xen gel implant for the treatment of open-angle glaucoma: a 3-year retrospective analysis. BMJ Open Ophthalmol. 2022;7(1):e000830. doi:10.1136/bmjophth-2021-000830
   PubMed Web of Science ®Google Scholar
• Marcos-Parra MT, Salinas-López JA, Mateos-Marcos C, Moreno-Castro L, Mendoza Moreira AL, Pérez-Santonja JJ. Long-term effectiveness of XEN 45 gel-stent in open-angle glaucoma patients. 2022. doi:10.21203/rs.3.rs-1514143/v1
   Google Scholar
• Hodapp E, Parrish R, Anderson D. Clinical Decisions in Glaucoma. St. Louis: Mosby-Year Book, Inc.; 1993.
   Google Scholar
• Gabbay IE, Allen F, Morley C, Pearsall T, Bowes OM, Ruben S. Efficacy and safety data for the XEN45 implant at 2 years: a retrospective analysis. Br J Ophthalmol. 2020;104(8):1125–1130. doi:10.1136/bjophthalmol-2019-313870
   PubMed Web of Science ®Google Scholar
• Mansouri K, Bravetti GE, Gillmann K, Rao HL, Ch’ng TW, Mermoud A. Two-year outcomes of XEN gel stent surgery in patients with open-angle glaucoma. Ophthalmol Glaucoma. 2019;2(5):309–318. doi:10.1016/j.ogla.2019.03.011
   PubMedGoogle Scholar
• Scheres LMJ, Kujovic-Aleksov S, Ramdas WD, et al. XEN® gel stent compared to PRESERFLO™ microshunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 2021;99(3):e433–e440. doi:10.1111/aos.14602
   PubMed Web of Science ®Google Scholar
• Subaşı S, Yüksel N, Özer F, Yılmaz Tugan B, Pirhan D. A retrospective analysis of safety and efficacy of XEN 45 microstent combined cataract surgery in open-angle glaucoma over 24 months. Turk J Ophthalmol. 2021;51(3):139–145. doi:10.4274/tjo.galenos.2020.47629
   PubMedGoogle Scholar
• Wanichwecharungruang B, Ratprasatporn N. 24-month outcomes of XEN45 gel implant versus trabeculectomy in primary glaucoma. PLoS One. 2021;16(8):e0256362. doi:10.1371/journal.pone.0256362
   PubMed Web of Science ®Google Scholar
• Nicolaou S, Khatib TZ, Lin Z, et al. A retrospective review of XEN implant surgery: efficacy, safety and the effect of combined cataract surgery. Int Ophthalmol. 2022;42(3):881–889. doi:10.1007/s10792-021-02069-5
   PubMed Web of Science ®Google Scholar
• Marcos-Parra MT, Mendoza-Moreira AL, Moreno-Castro L, et al. 3-year outcomes of XEN implant compared with trabeculectomy, with or without phacoemulsification for open angle glaucoma. J Glaucoma. 2022;31(10):826–833. doi:10.1097/IJG.0000000000002090
   PubMed Web of Science ®Google Scholar
• Mansouri K, Guidotti J, Rao HL, et al. Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results. J Glaucoma. 2018;27(2):140–147. doi:10.1097/IJG.0000000000000858
   PubMed Web of Science ®Google Scholar
• Chen XZ, Liang ZQ, Yang KY, et al. The outcomes of XEN gel stent implantation: a systematic review and meta-analysis. Front Med. 2022;9:804847. doi:10.3389/fmed.2022.804847
   Web of Science ®Google Scholar
• Wang B, Leng X, An X, Zhang X, Liu X, Lu X. XEN gel implant with or without phacoemulsification for glaucoma: a systematic review and meta-analysis. Ann Transl Med. 2020;8(20):1309. doi:10.21037/atm-20-6354
   PubMed Web of Science ®Google Scholar
• Gillmann K, Bravetti GE, Rao HL, Mermoud A, Mansouri K. Impact of phacoemulsification combined with XEN gel stent implantation on corneal endothelial cell density: 2-year results. J Glaucoma. 2020;29(3):155–160. doi:10.1097/IJG.0000000000001430
   PubMed Web of Science ®Google Scholar
• Oddone F, Roberti G, Posarelli C, et al. Endothelial cell density after XEN implant surgery: short-term data from the Italian XEN Glaucoma Treatment Registry (XEN-GTR). J Glaucoma. 2021;30(7):559–565. doi:10.1097/IJG.0000000000001840
   PubMed Web of Science ®Google Scholar